Lung Diseases, Obstructive  >>  QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
QVAR (beclomethasone dipropionate hydrofluoroalkane inhalation) / Teva
PAW01, NCT00829257 / 2008-001811-40: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

Completed
4
15
Europe
HFA-BDP, Fluticasone, Seretide
University of Dundee
Asthma
07/10
07/10
NCT00921921 / 2008-005909-19: Does Extra-fine Hydrofluoroalkane-beclomethasone Dipropionate (HFA-BDP) Suppress Small Airways Inflammation in Chronic Obstructive Pulmonary Disease (COPD)?

Completed
4
16
Europe
HFA-BDP, Qvar, Placebo
University of Dundee
COPD
10/11
10/11
NCT00826748: Effect of Inhaled Steroids on Gene Expression in the Lungs - 2

Terminated
4
24
US
Beclomethasone, QVAR 80 HFA
Weill Medical College of Cornell University
Chronic Obstructive Pulmonary Disease (COPD)
12/14
12/14
OLiVIA, NCT01741285 / 2012-005350-39: Effects of QVAR in Smokers With Asthma

Completed
4
40
Europe
Beclomethasone (QVAR), QVAR, Beclomethasone (Clenil), Clenil, Fluticasone, Flixotide
University Medical Center Groningen, Teva Pharma
Asthma
07/15
12/15

Download Options